en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
3/2021
vol. 59
 
Share:
Share:
more
 
 
abstract:
Short communication

COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity

Oksana Boyarchuk
1
,
Lilya Predyk
1
,
Iryna Yuryk
2

1.
Department of Children’s Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
2.
Regional Children’s Hospital, Ternopil, Ukraine
Reumatologia 2021; 59, 3: 197–199
Online publish date: 2021/07/11
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The aim of the study was to determine the frequency and the course of COVID-19 infection in children with juvenile idiopathic arthritis (JIA). The study involved 51 patients with JIA aged 2 to 18 years. Evidence of COVID-19 was found in 10 (19.6%) patients with JIA. COVID-19 infection occurred more often in patients with systemic arthritis (OR = 6.1667, 95% CI: 1.2053–31.5511, p = 0.0289). The course of COVID-19 infection in patients with JIA was generally similar to the course in the pediatric population, despite immunosuppressive therapy. In 3 out of 10 patients the infection caused an exacerbation of JIA, which required therapy escalation.
keywords:

COVID-19 infection, juvenile idiopathic arthritis, immunosuppressive therapy







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.